from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3359/-

LFCtreatmentdescriptionclass of inhibitor

0.252

Amikacinug/mL Amikacintranslation

-0.026

Cap5-10ug/mL Capreomycintranslation

-0.034

Rox10-50 ug/mL Roxithromycintranslation

-0.211

SM2-5 ug/mL Streptomycintranslation

0.732

Tet5-10 ug/mL Tetracyclinetranslation

1.783

Rif0.2-5ug/mL Rifampicintranscription

0.102

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.000

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.000

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.075

CPZ10-50 ug/mL Chlorpromazinerespiration

0.000

Clofazimine10-13 ug/mL Clofaziminerespiration

0.384

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.000

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.000

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.885

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.142

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.000

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.368

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.000

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.000

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.000

KCN5-20 ug/mL Potassium cyaniderespiration

0.000

NaN30.2-2 mM Sodium aziderespiration

0.000

Nigericin50 uM Nigericinrespiration

0.807

TRC10-150 ug/mL Triclosanrespiration

0.000

TRZ10-25 ug/mL Thioridazinerespiration

0.000

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

2.737

menadione6-10 ug/mL Menadionerespiration

0.510

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.298

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.070

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.000

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.000

NRP_1Non-replicating persistence stage 1dosRassociated

-0.625

Amp0.2mg/mL AmpicillincellWall

-0.636

Cephalexin20-100 ug/mL CephalexincellWall

0.835

Cerulenin0.32-5 ug/mL CerulenincellWall

0.369

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.183

EMB10-20 ug/mL EthambutolcellWall

-0.704

Eta12-40 ug/mL EthionamidecellWall

-0.973

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.067

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.000

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.000

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.641

BZA0.12 mg/mL BenzamidearomaticAmides

0.126

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.704

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.706

H2O24 mM hydrogen peroxideDNAdamaging

0.455

Levo10 ug/mL LevofloxacinDNAdamaging

-0.887

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.000

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.219

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.264

UVUV-irradiationDNAdamaging

0.000

ARP41-4 ug/mL Antitubercular compound ARP4?

0.231

Antimycin12.5-50 ug/mL Antimycin A?

0.000

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.439

PA_110-50 ug/mL Antitubercular compound PA-1?

0.227

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.838

PA8240.2-2 ug/mL PA-824?

0.580

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.134

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.000

Verapamil50 uM Verapamil?

2.110

mercaptoethanol2 mM 2-Mercaptoethanol?

0.000

methoxatin10-20 ug/mL Methoxatin?